Stryker (SYK) Assets Average (2009 - 2026)
Stryker's (SYK) quarterly Assets Average came in at $47.1 billion in Q2 2026, up 2.04% year-over-year from $46.2 billion in Q2 2025, and little changed quarter-over-quarter from $47.1 billion in Q1 2026.
Analysis
Stryker (SYK) Assets Average (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Assets Average for 18 consecutive years, with $47.1 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets Average rose 2.04% year-over-year to $47.1 billion in Q2 2026; TTM through Jun 2026 was $47.1 billion, a 2.04% increase from a year earlier, with the FY2025 full-year figure at $45.4 billion, up 9.57% from the prior year.
- Assets Average was $47.1 billion for Q2 2026 at Stryker, roughly flat from $47.1 billion in the prior quarter.
- Over five years, Assets Average peaked at $47.5 billion in Q4 2025 and troughed at $35.4 billion in Q1 2022.
- A 5-year average of $41.0 billion and a median of $39.5 billion in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average advanced 17.58% in 2025 and climbed 2.04% in 2026, its largest moves.
- Over 5 years, Assets Average stood at $36.4 billion in 2022, then climbed by 6.98% to $39.0 billion in 2023, then increased by 11.35% to $43.4 billion in 2024, then increased by 9.33% to $47.5 billion in 2025, then decreased by 0.72% to $47.1 billion in 2026.
- The last three Assets Average figures came in at $47.1 billion (Q2 2026), $47.1 billion (Q1 2026), and $47.5 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 22.76 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.11 Bn |
| Mar 31, 2026 | 47.07 Bn |
| Dec 31, 2025 | 47.45 Bn |
| Sep 30, 2025 | 46.69 Bn |
| Jun 30, 2025 | 46.17 Bn |
| Mar 31, 2025 | 44.49 Bn |
| Dec 31, 2024 | 43.40 Bn |
| Sep 30, 2024 | 41.48 Bn |
| Jun 30, 2024 | 39.27 Bn |
| Mar 31, 2024 | 39.66 Bn |
| Dec 31, 2023 | 38.98 Bn |
| Sep 30, 2023 | 37.73 Bn |
| Jun 30, 2023 | 37.12 Bn |
| Mar 31, 2023 | 36.86 Bn |
| Dec 31, 2022 | 36.43 Bn |
| Sep 30, 2022 | 36.01 Bn |
| Jun 30, 2022 | 36.08 Bn |
| Mar 31, 2022 | 35.38 Bn |
| Dec 31, 2021 | 34.39 Bn |
| Sep 30, 2021 | 33.92 Bn |